Hindustan Bio Sciences Ltd.

Information Technology · IT - Software

BSE: 532041
₹7.34
▲ 0.14 (1.94%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
20/100
Weak
Valuation
—/100
Expensive
Momentum
16/100
Bearish

QVM read Weak on all three Quality Weak, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹8 Cr
PE (TTM)
Data unavailable.
Price to Book
9.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-22.4
Free Cash Flow
₹0 Cr
as of March 31, 2026
Industry median ₹0 Cr (143 companies)
EPS Growth (YoY)
-110100.00%
as of June 30, 2026
Industry median -8.25% (122 companies)
Net Profit Growth (TTM)
-767.74%
as of June 30, 2026
Industry median 3.49% (121 companies)
Operating Revenue Growth (TTM)
-0.40%
as of June 30, 2026
Industry median 8.06% (119 companies)
Profit Growth (YoY)
-907.14%
as of June 30, 2026
Industry median 9.11% (122 companies)
Revenue Growth (YoY)
-21.65%
as of June 30, 2025
Industry median 9.67% (113 companies)
Current Ratio
38.80
as of March 31, 2026
Industry median 2.53 (141 companies)
Debt to Equity
2.84
as of March 31, 2026
Industry median 0.00 (129 companies)
Interest Coverage
-344.00
as of June 30, 2026
Industry median 17.20 (117 companies)
Net Margin
21.41%
as of Dec. 31, 2025
Industry median 11.85% (119 companies)
Operating Margin (EBIT)
21.54%
as of Dec. 31, 2025
Industry median 14.98% (120 companies)
Operating Margin (TTM)
-13.84%
as of June 30, 2026
Industry median 15.28% (122 companies)
Return on Assets
-2.50%
as of March 31, 2026
Industry median 5.12% (122 companies)
Return on Capital Employed
-2.48%
as of March 31, 2026
Industry median 9.62% (121 companies)
Return on Equity
-9.69%
as of March 31, 2026
Industry median 9.08% (123 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (2.84)
  • No Return on equity is 15% or more (-9.7%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.9%
Low 6.8400 · High 7.4400
1W return
1.9%
Low 6.6800 · High 7.8200
1M return
-11.7%
Low 6.6800 · High 8.4800
52W return
-31.5%
Low 6.3300 · High 9.1400
Lifetime High ₹15.0000 (Jan. 7, 2008)
Lifetime Low ₹0.3700 (Dec. 29, 2017)

Full price history and technicals →

EMA & SMA

Bullish2
Bearish4
5D
7.3
10D
7.3
20D
7.4
50D
7.6
100D
7.9
200D
8.5

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
96.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

7.21
Pivot
First resistance7.57
Second resistance7.81
Third resistance8.17
First support6.97
Second support6.61
Third support6.37
Day RSI48.2
Day MFI54.6
Day MACD-0.11
Day MACD signal-0.09

Beta

1M-1.07
3M-0.66
1Y-0.66
3Y-0.02

Price change analysis

↓ -11.7%
Over 1 Month
LowHigh
6.688.48
↓ -31.5%
Over 3 Months
LowHigh
6.339.14
↓ -31.5%
Over 6 Months
LowHigh
6.339.14
↓ -31.5%
Over 1 Year
LowHigh
6.339.14
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹— Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-11.0000

Ranks #112 of 126 in IT - Software by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter12.19%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 12.19% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
27 Oct 2025 RATNESH YOGESH BHONSLE Bulk Sell 53,501 6.5700 BSE
23 Oct 2025 VANDANA YOGESH BHOSALE Bulk Sell 106,518 7.2900 BSE
23 Oct 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 7,902 13.4700 BSE
23 Oct 2024 VIVEK KANDA Bulk Buy 52,500 13.4600 BSE
23 Oct 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 84,000 13.4600 BSE
17 Oct 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 53,601 11.0900 BSE
20 Oct 2023 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 65,000 13.7800 BSE
18 Oct 2023 JAI VINAYAK SECURITIES Bulk Buy 53,680 12.4800 BSE
18 Oct 2023 JAI VINAYAK SECURITIES Bulk Sell 53,680 12.3700 BSE
17 Oct 2023 BP EQUITIES PVT. LTD. Bulk Buy 33,939 11.3700 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Garuda Cements Ltd. to Hindustan Bio Sciences Ltd.
—NAME_CHANGEName changed from Hindustan Softel Ltd. to Hindustan Bio Sciences Ltd.

All corporate actions →

Corporate Announcements

All 4 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 AGM/EGM Hindustan Bio Sciences Ltd - 532041 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Hindustan Bio Sciences Ltd - 532041 - Proceedings Of AGM
30 Sep 2026 AGM/EGM Hindustan Bio Sciences Ltd - 532041 - Shareholder Meeting / Postal Ballot-Outcome of AGM
5 Sep 2026 Company Update Hindustan Bio Sciences Ltd - 532041 - Announcement under Regulation 30 (LODR)-Newspaper Publication

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (21.4%)

Weaknesses

  • Low Return on Equity (-9.7%)
  • High financial leverage (Debt/Equity 2.84)
  • Declining revenue YoY (-21.7%)
  • Declining profit YoY (-907.1%)

Opportunities

Data unavailable.

Threats

  • Down 31.5% over the past year
  • Weak interest coverage (-344.0x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Hindustan Bio Sciences Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.